Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among Patients with NSCLC and the Risk of Death From Any Cause Among Patients with Solid Tumours By Ogkologos - May 7, 2025 693 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the analysis of TRACERx and MSK-IMPACT studies Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Daughter Surprises Terminally Ill Mom With Graduation Ceremony In Hospital Room. May 16, 2019 How Exercise Can Help You Cope With the Mental and Emotional... August 18, 2022 Undetectable MRD and Extended PFS More Common with MRD-guided Ibrutinib-Venetoclax than... October 13, 2025 First immunotherapy approved for cervical cancer in England and Scotland May 16, 2023 Load more HOT NEWS ESMO Award for Immuno-Oncology 2025 Recipient Announced Enzalutamide Plus ADT Significantly Prolongs Survival in Patients with Metastatic Hormone-Sensitive... Advancing Cancer Research as a Married Couple: “Your Stories” Podcast Keeping A Jasmine Plant In Your Room Reduces Anxiety, Panic Attacks...
